In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Tectonic Therapeutic Inc (NASDAQ: TECX) closed the day trading at $18.37 up 2.45% from the previous closing price of $17.93. In other words, the price has increased by $2.45 from its previous closing price. On the day, 1.62 million shares were traded. TECX stock price reached its highest trading level at $18.8049 during the session, while it also had its lowest trading level at $17.91.
Ratios:
For a better understanding of TECX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.60 and its Current Ratio is at 25.60. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on October 20, 2025, initiated with a Overweight rating and assigned the stock a target price of $101.
On September 03, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $80.
On July 21, 2025, Truist started tracking the stock assigning a Buy rating and target price of $64.Truist initiated its Buy rating on July 21, 2025, with a $64 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 11 ’25 when SPRINGER TIMOTHY A bought 53,706 shares for $16.31 per share. The transaction valued at 875,945 led to the insider holds 1,503,358 shares of the business.
SPRINGER TIMOTHY A bought 45,858 shares of TECX for $767,204 on Apr 10 ’25. The Director now owns 1,449,652 shares after completing the transaction at $16.73 per share. On Apr 09 ’25, another insider, SPRINGER TIMOTHY A, who serves as the Director of the company, bought 21,071 shares for $14.76 each. As a result, the insider paid 311,020 and bolstered with 1,403,794 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECX now has a Market Capitalization of 343818080 and an Enterprise Value of 76621064.
Stock Price History:
The Beta on a monthly basis for TECX is 1.60, which has changed by -0.6220489 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, TECX has reached a high of $61.07, while it has fallen to a 52-week low of $13.70. The 50-Day Moving Average of the stock is -1.25%, while the 200-Day Moving Average is calculated to be -7.94%.
Shares Statistics:
Over the past 3-months, TECX traded about 494.99K shares per day on average, while over the past 10 days, TECX traded about 230530 shares per day. A total of 18.72M shares are outstanding, with a floating share count of 10.47M. Insiders hold about 44.07% of the company’s shares, while institutions hold 59.89% stake in the company. Shares short for TECX as of 1764288000 were 5089794 with a Short Ratio of 10.28, compared to 1761868800 on 4824160. Therefore, it implies a Short% of Shares Outstanding of 5089794 and a Short% of Float of 47.849998.
Earnings Estimates
The dynamic stock of Tectonic Therapeutic Inc (TECX) is currently attracting attention from 6.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$1.25, with high estimates of -$1.19 and low estimates of -$1.3.
Analysts are recommending an EPS of between -$3.99 and -$4.72 for the fiscal current year, implying an average EPS of -$4.21. EPS for the following year is -$4.82, with 8.0 analysts recommending between -$3.84 and -$5.45.
